MedPath

KOTRA PHARMA (HONG KONG) COMPANY

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

PPB:44

Drug Approvals

AXCEL PROMETHAZINE-5 SYRUP 5MG/5ML

Approval Date
Dec 29, 2017
PPB

AXCEL FLEMIN EXPECTORANT SYRUP

Approval Date
Nov 22, 2016
PPB

AXCEL CETIRIZINE SYRUP 5MG/5ML

Approval Date
Aug 30, 2016
PPB

AXCEL MOMETASONE OINTMENT 0.1%W/W

Approval Date
Aug 4, 2016
PPB

VAXCEL HEPARIN SODIUM SOLUTION FOR INJECTION 5000IU/ML

Approval Date
Jun 1, 2016
PPB

AXCEL NASATAB TABLETS

Approval Date
May 4, 2016
PPB

AXCEL OXYMETAZOLINE NASAL SPRAY 0.05%W/V

Approval Date
May 4, 2016
PPB

AXCEL CEPHALEXIN-125 POWDER FOR ORAL SUSPENSION 125MG/5ML

Approval Date
May 4, 2016
PPB

AXCEL MOMETASONE CREAM 0.1%W/W

Approval Date
Mar 8, 2016
PPB

AXCEL CHLORPHENIRAMINE-4 SYRUP 4MG/5ML

Approval Date
Feb 5, 2016
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.